Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
Subscribe To Our Newsletter & Stay Updated